Trial NCT00301795

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-03080
Secondary IDs: CALGB 50404 CDR0000462385 U10CA031946

Last trial update was posted on 2013-01-07

MeSH Interventions

Oblimersen Rituximab

MeSH Conditions

Lymphoma Lymphoma, Follicular Lymphoma, Non-Hodgkin

Other Conditions

Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID